Analysts cut target for Nanosonics stock to AUD 3.88
Published on 10/13/2026 at 00:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS- Analysts cut the average Nanosonics price target from AUD 4.23 to AUD 3.88 on September 25, 2026.
- Fiscal year 2026 revenue reached AUD 203.90 million, up 2.70 percent from fiscal year 2025.
- Nanosonics was last at EUR 1.79 at Lang & Schwarz on October 12, 2026 at 11:00 p.m. CEST.
- The company expects fiscal year 2027 revenue of AUD 220.00 million to AUD 228.00 million.
Nanosonics stock (ISIN AU000000NAN9) had an average analyst target cut from AUD 4.23 to AUD 3.88 on September 25, 2026, according to Simply Wall St. The reduction was 8.20 percent, based on an average of seven analysts, giving investors a lower valuation reference as Nanosonics prepares the commercial launch of CORIS.
Three milestones shape the story
On August 25, 2026, Nanosonics reported fiscal year 2026 revenue of AUD 203.90 million, up 2.70 percent from fiscal year 2025, while reported EBIT was AUD 16.00 million, according to Yahoo Finance.
On September 17, 2026, The Motley Fool Australia reported that RBC Capital Markets raised its Nanosonics target from AUD 3.00 to AUD 3.75 and that the company announced a fiscal year 2027 buyback of up to AUD 40.00 million.
On October 8, 2026, the CORIS System received a Gold award in the medical and scientific product design category at the Australian Good Design Awards, Investing News Network reported. CORIS automates cleaning of flexible endoscopes before high-level disinfection, adding a second technology platform beside trophon.
What does CORIS add?
Nanosonics entered fiscal year 2027 with revenue guidance of AUD 220.00 million to AUD 228.00 million at constant currency, representing growth of 8.00 percent to 12.00 percent from fiscal year 2026, according to Yahoo Finance. Management also expects the gross profit margin to reach 74.00 percent to 76.00 percent, while CORIS is scheduled for commercial launch in the first half of fiscal year 2027.
The operational leverage remains concentrated in trophon. Fiscal year 2026 trophon placements reached 4,230 units, up 9.00 percent, and the installed base reached 39,230 devices, up 6.00 percent. The contrast is important: the established platform generated reported EBIT of AUD 50.60 million, while CORIS requires additional investment before its commercial contribution becomes material.
Next date for shareholders
Nanosonics is scheduled to hold its annual general meeting on November 4, 2026, according to Simply Wall St. The meeting provides the next dated corporate checkpoint after the target revision and the CORIS award.
Stock stays below the analyst target
The last Lang & Schwarz quote was EUR 1.79 on October 12, 2026 at 11:00 p.m. CEST. Nanosonics had a market capitalization of AUD 851.90 million and a 52-week range of AUD 2.64 to AUD 4.76 as of October 12, 2026.
The further course of trading is shown by the continuously updated real-time quote of Nanosonics stock.
Nanosonics stock facts
- Company: Nanosonics Limited
- ISIN: AU000000NAN9
- Ticker: NAN
- Primary exchange: ASX
- Price Lang & Schwarz (as of October 12, 2026, 11:00 p.m. CEST): EUR 1.79
- Market capitalization: AUD 851.90 million (as of October 12, 2026)
- 52-week range: AUD 2.64-4.76 (as of October 12, 2026)
- Sector / Industry: Health Care / Medical Instruments and Supplies
Market context: Latest market reports.
